PREVALENCE OF DYSLIPIDEMIA AND OTHER CARDIOVASCULAR RISK FACTORS (HYPERTENSION AND DIABETES) IN MEDICAL PROFESSIONALS

The strong epidemiological relationship between specific lipoprotein levels (such as elevated low-density lipoprotein, cholesterol or decreased high density lipoprotein cholesterol) and the future development of coronary heart disease is well documented. Within the past several years landmark clinical trials have clearly demonstrated that the incidence of coronary heart disease events is reduced when lipoprotein abnormalities are corrected via pharmacological therapy. These findings have promoted clinicians to become more vigilant with regard to dyslipidemias and institution of treatment. The same is true of diabetes mellitus and hypertension which are also risk factors for coronary artery disease.